Keeping Track: Turalio, Nubeqa And Accrufer Mark Trio Of Novel Drug Approvals

05 Aug 2019

• By Michael Cipriano and Bridget Silverman

The latest drug development news and highlights from our US FDA Performance Tracker.

More from Approvals